Get the Stockscreener App
3.50
12.50%
-0.50
Pre-market:
3.81
0.31
+8.86%
Traws Pharma Inc Stock (TRAW) Latest News
TRAW stock touches 52-week low at $4.06 amid market challenges - Investing.com UK
Traws Pharma Reports Positive Phase 1 Results for Influenza Therapy Tivoxavir Marboxil - MSN
Traws Pharma amends Series A Warrant terms - Investing.com
Traws Pharma amends Series A Warrant terms By Investing.com - Investing.com UK
Traws Pharma secures stockholder nod for warrant issuance By Investing.com - Investing.com Nigeria
Traws Pharma secures stockholder nod for warrant issuance - Investing.com India
Traws Pharma, Expert Systems: Breakthrough in H5N1Bird Flu antiviral program - MSN
Onconova Therapeutics Announces Completion of Enrollment of Phase 3 Inspire Trial -March 24, 2020 at 04:05 pm EDT - Marketscreener.com
Traws Pharma completes Phase I trials of H5N1 bird flu treatment drug - MSN
Traws Pharma Names Nora Brennan Interim CFO -February 07, 2025 at 04:43 pm EST - Marketscreener.com
Traws Pharma Inc. Announces CFO Changes -February 07, 2025 at 04:31 pm EST - Marketscreener.com
Orbimed Advisors LLC Expands Stake in Traws Pharma Inc - GuruFocus.com
Traws Pharma Advances Bird Flu Treatment with Successful Phase I Trial - MSN
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu - Marketscreener.com
Traws Pharma's Bird Flu Drug Shows Promise in Phase I Safety Trial, Targets H5N1 Prevention - StockTitan
Traws Pharma Shares Surge 57% in After-Hours Trading Following Antiviral Trial Update - Yahoo Finance
Traws Pharma (TRAW) Stock Skyrockets In After-Hour Trading - Stocks Telegraph
Traws Pharma Shares Surge 57% in After-Hours Trading Following A - GuruFocus.com
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program - The Malaysian Reserve
Traws stock rallies 24% on avian flu drug update - MSN
Expert Systems And Traws Pharma Report Breakthrough In H5n1bird Flu Antiviral Program - MENAFN.COM
PERCEPTIVE ADVISORS LLC Acquires Significant Stake in Traws Phar - GuruFocus.com
Traws Pharma Secures $72.6 Million for Bird Flu Treatment Development - MSN
SEC Form 424B4 filed by Traws Pharma Inc. - Quantisnow
Traws Pharma secures up to $72.6 million in funding By Investing.com - Investing.com Canada
Traws stock plunges 43% on financing update - MSN
Traws Pharma, Inc. announced that it expects to receive $72.6 million in funding - Marketscreener.com
Is Traws Pharma Inc (NASDAQ: TRAW) Doomed From The Get-Go? - Stocks Register
Bucks County firm's shares plunge on capital raise plan - The Business Journals
Traws stock plunges 43% on financing update (TRAW:NASDAQ) - Seeking Alpha
Crude Oil Gains 1%; Chicago PMI Falls In December - Benzinga
Stock market news: Abpro Holdings -52.75%, Traws Pharma -42.47% among biggest losers during mid day trading - Business Upturn
Dismal Market Sentiment Pushes VIX Higher - Schaeffers Research
Traws Pharma Secures $72.6 Million in Financing to Advance Bird Flu Treatment Development - Tandav Media
Stock market today: Abpro Holdings -42.09%, Traws Pharma -39.26% among biggest losers in early trading - Business Upturn
Stock market news: Intrusion surged by 123.33% while Snow Lake Resources plunged by 21.88% in early trading - Business Upturn
Traws Pharma secures up to $72.6 million in funding - Investing.com India
Traws Pharma announces $72.6M financing - TipRanks
Traws Pharma Secures $72.6M Financing for Bird Flu Drug Development from Leading Healthcare Investors - StockTitan
Single Peoples' Personalities Differ from Partnered Peoples' - 69News WFMZ-TV
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval - Finansavisen
Traws Pharma stock soars 200% on encouraging bird flu drug data - MSN
Traws Pharma soars as it advances H5N1 bird flu treatment - The Pharma Letter
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
Traws Pharma, Inc. Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu - Marketscreener.com
Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November - Benzinga
Traws Pharma (TRAW) Shares Jump On Strong Trial Results - Stocks Telegraph
Traws Pharma Stock Rockets On Promising H5N1 Bird Flu Treatment Results - Benzinga
Traws Pharma Stock Hits 6-Month Highs On Bird Flu Treatment Breakthrough, Retail Interest Soars - MSN
Stock market news: Direct Digital Holdings +405.45%, Reliance Global Group +214.17% among top gainers during mid day trading - Business Upturn
Stock market news: Direct Digital Holdings up by 363.64% while iLearningEngines down by 70.88% during mid day trading - Business Upturn
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):